1 Min Read
May 17 (Reuters) - DelMar Pharmaceuticals Inc:
* DELMAR PHARMACEUTICALS ANNOUNCES THIRD QUARTER FISCAL YEAR 2018 FINANCIAL RESULTS
* Q3 LOSS PER SHARE $0.13 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.